Adaptive Biotechnologies annual meeting results: directors elected, say-on-pay approved, auditor ratified

Adaptive Biotechnologies Corp

Robert Hershberg elected Class I director with 71.81% of votes cast; 13.6M broker non-votes.
Katey Owen elected Class I director with 97.72% of votes cast.
Advisory vote on 2025 named executive officer compensation passed with 96.55% approval.
Ratification of Ernst & Young as auditor for FY 2026 approved with 99.50% of votes.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Adaptive Biotechnologies Corp shareholders approved Advisory request concerning compensation for the Company's 2025 named executive officers at the 2026-06-05 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-05

Exact text from the filing

Proposal 2: an advisory request concerning compensation for the Company's 2025 named executive officers

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Adaptive Biotechnologies Corp shareholders approved Ratification of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-05 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-05

Exact text from the filing

Proposal 3: Ramification of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for the Year Ending December 31, 2026

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Adaptive Biotechnologies Corp shareholders approved Election of two Class I directors to the Board of Directors (Robert Hershberg, PhD, MD and Katey Owen, PhD) at the 2026-06-05 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-05

Exact text from the filing

Proposal 1: election of two Class I directors to the Board of Directors (Robert Hershberg, PhD, MD and Katey Owen, PhD)

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Adaptive Biotechnologies Corp filing history →

Source: SEC EDGAR

accession 0001193125-26-263844

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.